About Kevin
Kevin Kabler moved from laboratory benches to the courtroom over the span of a decade. His academic path began at Kansas State University, where he earned a B.S. in Microbiology in 2001. He then pursued graduate work at Baylor College of Medicine, completing a Ph.D. in Immunology in 2005. After several years in scientific research he returned to law school and received his J.D. from the University of California College of the Law, San Francisco in 2011.
Those scientific credentials shape how he approaches legal problems. Early in his career he worked in research environments that required close attention to experimental detail and regulatory nuance. He carried that orientation into patent law, where technical precision and careful claim drafting matter. He is admitted to practice in California and before the U.S. Patent and Trademark Office, credentials that reflect the hybrid scientific-legal training he pursued.
Kabler joined Fenwick & West LLP, a firm known for its technology and life sciences practice groups. At Fenwick he has worked on matters that marry biology and patent strategy: drafting and prosecuting patent applications, advising on patent portfolio development, and counseling clients on patentability and freedom-to-operate issues. His background in immunology gives him direct familiarity with the kinds of experimental claims and data often at issue in biotech prosecution.
Colleagues describe him as methodical in preparing file histories and attentive when negotiating claim scope with examiners. He takes an analytical approach to prior art and inventorship questions. That mindset translates into work product aimed at durable patent protection rather than short-term advantage.
Outside the office, his shift from Ph.D. research to legal practice gives him particular perspective when briefing scientist-clients. He can translate bench methods into the legal arguments patent offices require. Clients in biotechnology and pharmaceuticals often rely on an attorney who understands both the laboratory context and the patent rules that apply to it.
As of 2026 he continues at Fenwick & West LLP practicing patent law. He handles patent prosecution, portfolio counseling, and related patent matters for biotechnology and pharmaceutical clients.
